Bellicum Pharmaceuticals, Inc.
IMPROVED FORMULATIONS FOR IMMUNE CELLS
Last updated:
Abstract:
We disclose various improvements for compositions of T cells, including the use of lower levels of serum albumin and of cryoprotectants such as dimethyl sulfoxide.
Status:
Application
Type:
Utility
Filling date:
12 Aug 2020
Issue date:
1 Sep 2022